SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences - Quaterly Results

14 Feb 2024 Evaluate
The December 2023 quarter revenue stood at Rs. 2017.78 millions, up 13.70% as compared to Rs. 1774.73 millions during the corresponding quarter last year.Profit saw a slight increase of 9.45%to Rs. 222.57  millions from Rs. 203.35 millions.Operating profit surged to 368.79 millions from the corresponding previous quarter of 341.48 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 2017.78 1774.73 13.70 6116.72 5175.84 18.18 6906.21 7791.56 -11.36
Other Income 4.24 7.57 -43.99 16.39 19.50 -15.95 25.74 31.04 -17.07
PBIDT 368.79 341.48 8.00 1129.42 1011.33 11.68 1372.25 1511.34 -9.20
Interest 31.79 21.60 47.18 117.13 46.74 150.60 82.23 53.66 53.24
PBDT 337.00 319.88 5.35 1012.29 964.59 4.95 1290.02 1457.68 -11.50
Depreciation 41.42 47.41 -12.63 126.75 136.70 -7.28 222.81 189.29 17.71
PBT 295.58 272.47 8.48 885.54 827.89 6.96 1067.21 1268.39 -15.86
TAX 73.01 69.12 5.63 224.63 211.90 6.01 270.16 309.98 -12.85
Deferred Tax 1.03 -0.38 -371.05 33.92 -8.20 -513.66 -11.94 -11.52 3.65
PAT 222.57 203.35 9.45 660.91 615.99 7.29 797.05 958.41 -16.84
Equity 100.28 96.94 3.45 100.28 96.94 3.45 96.94 96.94 0.00
PBIDTM(%) 18.28 19.24 -5.01 18.46 19.54 -5.50 19.87 19.40 2.44

Gufic Biosciences Share Price

292.70 -8.60 (-2.85%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×